Skip to main content
BNC Korea Co, Ltd logo

BNC Korea Co, Ltd — Investor Relations & Filings

Ticker · 256840 ISIN · KR7256840000 KO Manufacturing
Open in API
Filings indexed 283 across all filing types
Latest filing 2020-03-30 Annual Report
Country KR South Korea
Listing KO 256840

About BNC Korea Co, Ltd

http://www.bnckorea.co.kr

BNC Korea Co., Ltd. is a biomedical company established in 2007 that engages in the research, development, production, and sale of medical devices, pharmaceuticals, and biologicals. The company specializes in products derived from biomaterials, with a particular focus on hyaluronic acid. Its core product portfolio includes hyaluronic acid-based dermal fillers and botulinum toxin injectables for the medical aesthetics market. BNC Korea operates a GMP-certified facility for manufacturing cutting-edge drug substances and specialty medicines, aiming to develop strategic application products for next-generation bio markets.

Recent filings

Filing Released Lang Actions
사업보고서 (2019.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the fiscal year 2019 (Jan 1, 2019 to Dec 31, 2019) for the company 'BNC Korea'. It contains detailed sections on company overview, capital structure, business operations, and financial information. In the context of Korean corporate filings, the 'Business Report' (사업보고서) is the equivalent of the US 10-K annual report, as it provides the full annual financial performance and company activity. It is not an announcement or a summary, but the full report itself. FY 2019
2020-03-30 Korean
신규시설투자등
Capital/Financing Update Classification · 95% confidence The document is a regulatory announcement regarding a 'New Facility Investment' (신규시설투자) by the company Korea BNC. It details the investment amount, purpose (factory construction design change), and board approval date. This type of disclosure regarding capital expenditure and facility investment is a standard regulatory filing in the Korean market (DART system) and does not fit into specific categories like M&A, dividends, or earnings releases. Therefore, it is classified as a general Regulatory Filing (RNS).
2020-03-25 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, dividend decisions, and director appointments. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-03-24 Korean
감사보고서제출
Audit Report / Information Classification · 95% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from the company '한국비엔씨'. It provides the audit opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, profit/loss), and details about the external auditor. While it contains financial data, it is a specific regulatory disclosure regarding the completion and submission of the audit report, not the full annual report (10-K) itself. Therefore, it is classified as an Audit Report/Information document. FY 2019
2020-03-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Korea BNC) disclosing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (DART system) for listed companies to report material financial changes before the final audit is completed. It provides specific financial data and reasons for the variance, fitting the definition of a general regulatory announcement.
2020-03-09 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company '한국비엔씨'. It outlines the date, time, location, and the agenda items (such as approval of financial statements and director remuneration). This document serves as the official notification and proxy solicitation material for an upcoming Annual General Meeting, which falls under the category of Proxy Solicitation & Information Statement.
2020-03-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.